|
🐜
|
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
92 auth.
E. Volkmann,
D. Tashkin,
M. Kuwana,
Ning Li,
M. Roth,
J. Charles,
F. Hant,
G. Bogatkevich,
T. Akter,
G. Kim,
J. Goldin,
D. Khanna,
P. Clements,
D. Furst,
R. Elashoff,
...
R. Silver,
S. Assassi,
A. Theodore,
R. Simms,
E. Kissin,
F. Cheong,
V. Steen,
C. Read,
C. Fridley,
M. Zulmatashvili,
R. Wise,
F. Wigley,
L. Hummers,
G. Leatherman,
R. Silver,
C. Strange,
F. Hant,
J. Ham,
K. Gibson,
D. Rosson,
D. Tashkin,
R. Elashoff,
M. Roth,
P. Clements,
D. Furst,
E. Volkmann,
S. Kafaja,
E. Kleerup,
D. Elashoff,
J. Goldin,
E. Ariola,
G. Marlis,
J. Mason‐Berry,
P. Saffold,
Michael A. Rodriguez,
L. Guzmán,
J. Brook,
J. Golden,
M. Connolly,
A. Eller,
D Leong,
M. Lalosh,
J. Obata,
S. Volkov,
D. Schraufnagel,
S. Arami,
D. Franklin,
J. Varga,
J. Dematte,
M. Hinchcliff,
C. Deluca,
H. Donnelly,
C. Marlin,
D. Riley,
V. Hsu,
D. McCloskey,
K. Phillips,
D. Khanna,
F. Martinez,
E. Schiopu,
J. Konkle,
M. Mayes,
B. Patel,
S. Assassi,
F. Tan,
A. Fischer,
J. Swigris,
R. Meehan,
K. Brown,
T. Warren,
M. Morrison,
M. Scholand,
T. Frecht,
P. Carey,
M. Villegas,
J. Molitor,
P. Carlson
|
5 |
2019 |
5
🐜
|
|
🐜
|
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
92 auth.
E. Volkmann,
D. Tashkin,
M. Kuwana,
Ning Li,
M. Roth,
J. Charles,
F. Hant,
G. Bogatkevich,
T. Akter,
G. Kim,
J. Goldin,
D. Khanna,
P. Clements,
D. Furst,
R. Elashoff,
...
R. Silver,
S. Assassi,
A. Theodore,
R. Simms,
E. Kissin,
F. Cheong,
V. Steen,
C. Read,
C. Fridley,
M. Zulmatashvili,
R. Wise,
F. Wigley,
L. Hummers,
G. Leatherman,
R. Silver,
C. Strange,
F. Hant,
J. Ham,
K. Gibson,
D. Rosson,
D. Tashkin,
R. Elashoff,
M. Roth,
P. Clements,
D. Furst,
E. Volkmann,
S. Kafaja,
E. Kleerup,
D. Elashoff,
J. Goldin,
E. Ariola,
G. Marlis,
J. Mason‐Berry,
P. Saffold,
Michael A. Rodriguez,
L. Guzmán,
J. Brook,
J. Golden,
M. Connolly,
A. Eller,
D Leong,
M. Lalosh,
J. Obata,
S. Volkov,
D. Schraufnagel,
S. Arami,
D. Franklin,
J. Varga,
J. Dematte,
M. Hinchcliff,
C. Deluca,
H. Donnelly,
C. Marlin,
D. Riley,
V. Hsu,
D. McCloskey,
K. Phillips,
D. Khanna,
F. Martinez,
E. Schiopu,
J. Konkle,
M. Mayes,
B. Patel,
S. Assassi,
F. Tan,
A. Fischer,
J. Swigris,
R. Meehan,
K. Brown,
T. Warren,
M. Morrison,
M. Scholand,
T. Frecht,
P. Carey,
M. Villegas,
J. Molitor,
P. Carlson
|
5 |
2019 |
5
🐜
|
|
🐜
|
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
58 auth.
D. Sullivan,
K. Gebo,
S. Shoham,
E. Bloch,
B. Lau,
A. Shenoy,
G. Mosnaim,
T. Gniadek,
Yuriko Fukuta,
B. Patel,
S. Heath,
A. Levine,
B. Meisenberg,
E. Spivak,
S. Anjan,
...
M. Huaman,
J. Blair,
J. Currier,
J. Paxton,
Jonathan M Gerber,
J. Petrini,
P. Broderick,
W. Rausch,
M. Cordisco,
J. Hammel,
B. Greenblatt,
Valerie Cluzet,
D. Cruser,
Kevin Oei,
M. Abinante,
Laura L Hammit,
Catherine G Suttcliffe,
D. Forthal,
M. Zand,
E. Cachay,
J. Raval,
S. Kassaye,
Colin Foster,
M. Roth,
Christi E. Marshall,
Anusha Yarava,
K. Lane,
N. McBee,
Amy L. Gawad,
Nicky Karlen,
Atika Singh,
D. Ford,
D. Jabs,
L. Appel,
David M. Shade,
S. Ehrhardt,
S. Baksh,
O. Laeyendecker,
A. Pekosz,
S. Klein,
A. Casadevall,
A. Tobian,
D. Hanley
|
5 |
2021 |
5
🐜
|
|
🐜
|
FRI0396 Double-blind comparison of mycophenolate mofetil and oral cyclophosphamide for treatment of scleroderma-related interstitial lung disease (scleroderma lung study [SLS] II): rationale, design, methods, baseline characteristics and patient disposition
11 auth.
D. Khanna,
M. Roth,
D. Furst,
P. Clements,
J. Goldin,
E. Arriola,
...
J. Kotlerman,
Carol Tseng,
G. Kim,
R. Elashoff,
D. Tashkin
|
2 |
2013 |
2
🐜
|
|
🐜
|
Prognostic capability of the Maximum Acute Gastrointestinal Injury Score and of caloric intake in patients requiring vasopressors: A multicenter prospective cohort study.
18 auth.
C. Loudet,
M. Marchena,
Leandro Tumino,
M. Cabana,
G. Capurro,
P. Astegiano,
Mariela A Velásquez,
M. Casanova,
María J Rodríguez Bugueiro,
M. Roth,
...
Gisela Roda,
Rolando Gimbernat,
Yanina Del Valle Balmaceda,
Patricia Okurzaty,
M. Perman,
A. González,
R. Reina,
E. Estenssoro
|
2 |
2020 |
2
🐜
|
|
🐜
|
SAT0444 Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease
9 auth.
E. Volkmann,
D. Tashkin,
P. Clements,
M. Roth,
D. Furst,
D. Khanna,
...
C. Tseng,
E. Arriola,
R. Elashoff
|
2 |
2015 |
2
🐜
|
|
🐜
|
OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up
12 auth.
E. Volkmann,
M. Sim,
D. Tashkin,
D. Khanna,
P. Clements,
M. Roth,
...
D. Furst,
A. Pickney,
E. Goldmuntz,
L. Keyes‐Elstein,
R. Elashoff,
K. Sullivan
|
0 |
2017 |
0
🐜
|
